The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2
Clinical trial NCT04313023 · COMPLETED
Trial details
- NCT number
- NCT04313023
- Sponsor
- Pulmotect, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-09
- Primary completion
- 2021-07-31
- Enrollment
- 217
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.